{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:16:25Z","timestamp":1792800985429,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejmech.2024.116589","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T15:39:59Z","timestamp":1718206799000},"page":"116589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, \u03b1-amylase, and \u03b1-glucosidase inhibitors with molecular docking simulation"],"prefix":"10.1016","volume":"275","author":[{"given":"Hamdy","family":"Khamees Thabet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8542-7465","authenticated-orcid":false,"given":"Ahmed","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Hamdy","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Ibrahim Alaqel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abida","family":"Ash Mohd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek","family":"Rakan Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa","family":"S. Abusaif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousry","family":"A. Ammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116589_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/diabetology2020004","article-title":"Diabetes mellitus: Insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management","volume":"2","author":"Alam","year":"2021","journal-title":"Diabetology"},{"key":"10.1016\/j.ejmech.2024.116589_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/pop.2015.0181","article-title":"Diabetes 2030: insights from yesterday, today, and future trends","volume":"20","author":"Rowley","year":"2016","journal-title":"Popul. Health Manag."},{"key":"10.1016\/j.ejmech.2024.116589_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ejmech.2017.10.028","article-title":"Synthesis of piperazine sulfonamide analogs as diabetic-II inhibitors and their molecular docking study","volume":"141","author":"Taha","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115158","article-title":"A sulfonamide chalcone AMPK activator ameliorates hyperglycemia and diabetic nephropathy in db\/db mice","volume":"165","author":"Kaewin","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116589_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding and treatment of diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejmech.2024.116589_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/17460441.2018.1398731","article-title":"Novel avenues for drug discovery in diabetic kidney disease","volume":"13","author":"Breyer","year":"2018","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116589_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/ndt\/gfu411","article-title":"Diabetic nephropathy: landmark clinical trials and tribulations","volume":"31","author":"Chan","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejmech.2024.116589_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2047-783X-18-4","article-title":"Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus","volume":"18","author":"Zhuo","year":"2013","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.ejmech.2024.116589_bib9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nrd.2016.67","article-title":"The next generation of therapeutics for chronic kidney disease","volume":"15","author":"Breyer","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116589_bib10","doi-asserted-by":"crossref","first-page":"8411","DOI":"10.1021\/jf502667z","article-title":"\u03b1-Amylase inhibitory triterpene from Abrus precatorius leaves","volume":"62","author":"Yonemoto","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib11","doi-asserted-by":"crossref","first-page":"9281","DOI":"10.1039\/D3RA00297G","article-title":"Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis with molecular modeling simulations","volume":"13","author":"Hassan","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116589_bib12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/jsfa.4615","article-title":"\u03b1\u2010Amylase inhibitors from an Indonesian medicinal herb, Phyllanthus urinaria","volume":"92","author":"Gunawan\u2010Puteri","year":"2012","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.ejmech.2024.116589_bib13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nchembio.1865","article-title":"The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif","volume":"11","author":"Williams","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116589_bib14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ijbiomac.2018.08.001","article-title":"Antidiabetic and antiparasitic potentials: inhibition effects of some natural antioxidant compounds on \u03b1-glycosidase, \u03b1-amylase and human glutathione S-transferase enzymes","volume":"119","author":"Gul\u00e7in","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2024.116589_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bioorg.2015.09.008","article-title":"Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: in vitro studies against yeast \u03b1-glucosidase, acetylcholinesterase and butyrylcholinesterase","volume":"63","author":"Riaz","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib16","series-title":"Compr. Biotechnol.","first-page":"745","article-title":"4.60 - plant biochemistry: antifungal proteins protecting plants from fungal pathogens, in: m.B.T.-C.B","author":"Wong","year":"2011"},{"key":"10.1016\/j.ejmech.2024.116589_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diaspect.27.2.92","article-title":"Update on safety issues related to antihyperglycemic therapy","volume":"27","author":"Carpio","year":"2014","journal-title":"Diabetes Spectr. a Publ. Am. Diabetes Assoc."},{"key":"10.1016\/j.ejmech.2024.116589_bib18","series-title":"Nutr. Ther. Interv. Diabetes Metab. Syndr.","first-page":"455","article-title":"Chapter 34 current antidiabetic drugs: review of their efficacy and safety, in: D. Bagchi, S.B.T.N. And","author":"Hossain","year":"2018"},{"key":"10.1016\/j.ejmech.2024.116589_bib19","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1007\/s13738-022-02575-y","article-title":"Synthesis, characterization, and in vitro antibacterial activity of some new pyridinone and pyrazole derivatives with some in silico ADME and molecular modeling study","volume":"19","author":"Saadon","year":"2022","journal-title":"J. Iran. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116589_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.6508","article-title":"Coordination compounds of pyrazolone-based ligand: design, characterization, biological evaluation, antitumor efficiency, and DNA binding evaluation supported by in silico studies","volume":"36","author":"Ibrahim","year":"2022","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib21","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/ddr.21960","article-title":"A new exploration toward adamantane derivatives as potential anti-MDR agents: design, synthesis, antimicrobial, and radiosterilization activity as potential topoisomerase IV and DNA gyrase inhibitors","author":"Ragab","year":"2022","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2024.116589_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105473","article-title":"Synthesis, characterization, thermal properties, antimicrobial evaluation, ADMET study, and molecular docking simulation of new mono Cu (II) and Zn (II) complexes with 2-oxoindole derivatives","volume":"145","author":"Ragab","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejmech.2024.116589_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104164","article-title":"Design, synthesis, antimicrobial activity and molecular docking studies of some novel di-substituted sulfonylquinoxaline derivatives","volume":"104","author":"Ammar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105300","article-title":"In vivo screening and toxicity studies of indolinone incorporated thiosemicarbazone, thiazole and piperidinosulfonyl moieties as anticonvulsant agents","author":"Fayed","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib25","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.3c02279","article-title":"Discovery of novel pyridazine-tethered sulfonamides as carbonic anhydrase II inhibitors for the management of glaucoma","author":"Tawfik","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137118","article-title":"Novel benzothiazole sulfonamides as potent \u03b1-glucosidase and cholinesterase inhibitors: design, synthesis, structural properties, biological evaluation and docking studies","volume":"1299","author":"Khair-ul-Bariyah","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116589_bib27","article-title":"In vitro activity of novel 4-iminohydantoin sulfamide derivatives against human cytomegalovirus","author":"Zhirnov","year":"2023","journal-title":"Chem. Pap."},{"key":"10.1016\/j.ejmech.2024.116589_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ph15030376","article-title":"One-Pot synthesis and molecular modeling studies of new bioactive spiro-oxindoles based on uracil derivatives as SARS-CoV-2 inhibitors targeting RNA polymerase and spike glycoprotein","volume":"15","author":"El-Kalyoubi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2024.116589_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/biomedicines10030722","article-title":"Anticancer effects with molecular docking confirmation of newly synthesized isatin sulfonamide molecular hybrid derivatives against hepatic cancer cell lines","volume":"10","author":"Eldeeb","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2024.116589_bib30","doi-asserted-by":"crossref","first-page":"12589","DOI":"10.1039\/D3RA01635H","article-title":"A new class of anti-proliferative activity and apoptotic inducer with molecular docking studies for a novel of 1,3-dithiolo[4,5-b]quinoxaline derivatives hybrid with a sulfonamide moiety","volume":"13","author":"Ismail","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116589_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115180","article-title":"4-(5-Amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: design, synthesis, and biological assessments","volume":"250","author":"Ragab","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib32","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00044-019-02378-6","article-title":"Sulfa drug analogs: new classes of N-sulfonyl aminated azines and their biological and preclinical importance in medicinal chemistry (2000\u20132018)","volume":"28","author":"Elgemeie","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.116589_bib33","first-page":"1596","article-title":"Comparison of acute and prolonged effects of glibenclamide and chlorpropamide in patients with non-insulin-dependent diabetes","volume":"35","author":"Ylitalo","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejmech.2024.116589_bib34","article-title":"Synthesis, in vitro \u03b1-glucosidase, \u03b1-amylase inhibitory potential and molecular docking study of thiadiazole-sulfonamide hybrid analogues","volume":"46","author":"Ullah","year":"2023","journal-title":"Chem. Data Collect."},{"key":"10.1016\/j.ejmech.2024.116589_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104808","article-title":"Evaluation and docking of indole sulfonamide as a potent inhibitor of \u03b1-glucosidase enzyme in streptozotocin \u2013induced diabetic albino wistar rats","volume":"110","author":"Taha","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/23328940.2021.1886392","article-title":"Paracetamol (acetaminophen): a familiar drug with an unexplained mechanism of action","volume":"8","author":"Ayoub","year":"2021","journal-title":"Temperature"},{"key":"10.1016\/j.ejmech.2024.116589_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011534.pub2","article-title":"Paracetamol (acetaminophen) or non\u2010steroidal anti\u2010inflammatory drugs, alone or combined, for pain relief in acute otitis media in children","author":"Sjoukes","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2024.116589_bib38","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2165\/11205830-000000000-00000","article-title":"Tramadol\/paracetamol fixed-dose combination","volume":"30","author":"Dhillon","year":"2010","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ejmech.2024.116589_bib39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.japh.2018.05.012","article-title":"Exceeding the maximum daily dose of acetaminophen with use of different single-ingredient OTC formulations","volume":"58","author":"Shiffman","year":"2018","journal-title":"J. Am. Pharmaceut. Assoc."},{"key":"10.1016\/j.ejmech.2024.116589_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115138","article-title":"Development of novel pyrazole, imidazo[1,2-b]pyrazole, and pyrazolo[1,5-a]pyrimidine derivatives as a new class of COX-2 inhibitors with immunomodulatory potential","volume":"249","author":"Ayman","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135671","article-title":"Discovery a novel of thiazolo[3,2-a]pyridine and pyrazolo[3,4-d]thiazole derivatives as DNA gyrase inhibitors; design, synthesis, antimicrobial activity, and some in-silico ADMET with molecular docking study","volume":"1287","author":"Mohamed","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116589_bib42","doi-asserted-by":"crossref","first-page":"34756","DOI":"10.1039\/D3RA07040A","article-title":"One-pot synthesis of pyrazolo[4,3-d]thiazole derivatives containing \u03b1-aminophosphonate as potential Mur A inhibitors against MDR pathogens with radiosterilization and molecular modeling simulation","volume":"13","author":"Ragab","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116589_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106307","article-title":"Development of new spiro[1,3]dithiine-4,11\u2032-indeno[1,2-b]quinoxaline derivatives as S. aureus Sortase A inhibitors and radiosterilization with molecular modeling simulation","volume":"131","author":"Ragab","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bioorg.2015.04.004","article-title":"Design and synthesis of newer potential 4-(N-acetylamino)phenol derived piperazine derivatives as potential cognition enhancers","volume":"60","author":"Piplani","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib45","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1007\/s11164-019-03914-0","article-title":"Synthesis, characterization, and antioxidant activity of thymol-based paracetamol analogues","volume":"45","author":"Sathe","year":"2019","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ejmech.2024.116589_bib46","first-page":"651","article-title":"Antimicrobial activities of novel synthesized Cu (II) and Co (II) mixed ligand complexes of prednisolone and paracetamol","volume":"10","author":"Olagboye","year":"2020","journal-title":"Int. J. Sci. Eng. Res."},{"key":"10.1016\/j.ejmech.2024.116589_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131758","article-title":"Synthesis, crystal structure, DFT and anticancer study of dihydroartermisinin-paracetamol hybrids","volume":"1250","author":"Liu","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116589_bib48","first-page":"395","article-title":"Synthesis and biological evaluation of novel paracetamol-triazole conjugates TT - yeni parasetamol-triazol konjugatlar\u0131n\u0131n Sentezi ve Biyolojik De\u011ferlendirmesi","volume":"48","author":"K\u00fc\u00e7\u00fckg\u00fczel","year":"2023","journal-title":"Fabad J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2024.116589_bib49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12551-021-00795-9","article-title":"Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions","volume":"13","author":"Ovung","year":"2021","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.ejmech.2024.116589_bib50","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1021\/acs.jmedchem.5b00764","article-title":"Design, synthesis, and biological activity of sulfonamide analogues of Antofine and cryptopleurine as potent and orally active antitumor agents","volume":"58","author":"Kwon","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib51","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/ejoc.200300620","article-title":"Chemoselective acylation of amines in aqueous media","volume":"2004","author":"Naik","year":"2004","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104497","article-title":"Synthesis, molecular docking, and in silico ADME\/Tox profiling studies of new 1-aryl-5-(3-azidopropyl)indol-4-ones: potential inhibitors of SARS CoV-2 main protease","volume":"106","author":"Dom\u00ednguez-Villa","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib53","doi-asserted-by":"crossref","DOI":"10.1515\/hc-2022-0170","article-title":"Synthesis, characterization, and biological target prediction of novel 1,3-dithiolo[4,5-b]quinoxaline and thiazolo[4,5-b]quinoxaline derivatives","volume":"29","author":"El-Gaby","year":"2023","journal-title":"Heterocycl. Commun."},{"key":"10.1016\/j.ejmech.2024.116589_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-50130-3","article-title":"Developing a new multi-featured chitosan-quinoline Schiff base with potent antibacterial, antioxidant, and antidiabetic activities: design and molecular modeling simulation","volume":"13","author":"Abdel-Baky","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116589_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ddr.22008","article-title":"In vitro enzymatic evaluation of some pyrazolo[1,5-a]pyrimidine derivatives: design, synthesis, antioxidant, anti-diabetic, anti-Alzheimer, and anti-arthritic activities with molecular modeling simulation","volume":"84","author":"Hassan","year":"2023","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2024.116589_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202103848","article-title":"Synthesis, in-vitro evaluation and molecular docking study of N-substituted thiazolidinediones as \u03b1-glucosidase inhibitors","volume":"7","author":"Patil","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2024.116589_bib57","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/cbdd.14154","article-title":"Development and radiosterilization of new hydrazono-quinoline hybrids as DNA gyrase and topoisomerase IV inhibitors: antimicrobial and hemolytic activities against uropathogenic isolates with molecular docking study","volume":"101","author":"Ammar","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2024.116589_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134443","article-title":"A novel of quinoxaline derivatives tagged with pyrrolidinyl scaffold as a new class of antimicrobial agents: design, synthesis, antimicrobial activity, and molecular docking simulation","volume":"1274","author":"Abdelgalil","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116589_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.pestbp.2024.105943","article-title":"New prospective insecticidal agents based on thiazolo[4,5-b]quinoxaline derivatives against cotton leafworm Spodoptera litura (Fabricius): design, synthesis, toxicological, morphology, histological, and biomedical studies","volume":"202","author":"Ragab","year":"2024","journal-title":"Pestic. Biochem. Physiol."},{"key":"10.1016\/j.ejmech.2024.116589_bib60","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/cbdd.13893","article-title":"Biological evaluation the 2-aryl-2,3-dihydrobenzodiazaborinin-4(1H)-ones as potential dual \u03b1-glucosidase and \u03b1-amylase inhibitors with antioxidant properties","volume":"98","author":"Mphahlele","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2024.116589_bib61","doi-asserted-by":"crossref","first-page":"15691","DOI":"10.1039\/D4RA02143F","article-title":"Innovation of 6-sulfonamide-2H-chromene derivatives as antidiabetic agents targeting \u03b1-amylase, \u03b1-glycosidase, and PPAR-\u03b3 inhibitors with in silico molecular docking simulation","volume":"14","author":"Thabet","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116589_bib62","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2292482","article-title":"Comparative metabolic study of the chloroform fraction of three Cystoseira species based on UPLC\/ESI\/MS analysis and biological activities","volume":"39","author":"Aly","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108097","article-title":"Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting \u03b1-glucosidase, \u03b1-amylase, and PPAR-\u03b3: design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus","volume":"111","author":"Thabet","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200395","article-title":"Discovery of novel pyrazole and pyrazolo[1,5-a]pyrimidine derivatives as cyclooxygenase inhibitors (COX-1 and COX-2) using molecular modeling simulation","volume":"356","author":"Ayman","year":"2023","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2024.116589_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/aoc.7238","article-title":"Photocatalytic activity of co-doped NPs based on ZnO as a new class of anti-microbial agents: synthesis, characterization, kinetics, isotherm, and in silico molecular docking simulation","volume":"37","author":"Basseem","year":"2023","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2024.116589_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14786419.2024.2335666","article-title":"Utilising UPLC-QTOF-MS\/MS to determine the phytochemical profile and in vitro cytotoxic potential of Ziziphora capitata L. with molecular docking simulation","author":"Youssif","year":"2024","journal-title":"Nat. Prod. Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424004690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424004690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T09:26:14Z","timestamp":1720430774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424004690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":66,"alternative-id":["S0223523424004690"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116589","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, \u03b1-amylase, and \u03b1-glucosidase inhibitors with molecular docking simulation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116589","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116589"}}